ACE and stroke disorder: The data revealed that only 48% of chronic heart disease (CHD) patients received beta blockers, 40% of CHD patients and 38% of stroke patients received ACE inhibitors, and 30% of CHD patients and 14% of stroke patients could receive statins (Mendis et al., 2005).